Dimensional Fund Advisors LP Buys 2,126 Shares of Axon Enterprise, Inc $AXON

Dimensional Fund Advisors LP increased its stake in Axon Enterprise, Inc (NASDAQ:AXON) by 1.3% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 161,740 shares of the biotechnology company’s stock after acquiring an additional 2,126 shares during the quarter. Dimensional Fund Advisors LP’s holdings in Axon Enterprise were worth $68,681,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Parallel Advisors LLC increased its position in shares of Axon Enterprise by 7.2% during the first quarter. Parallel Advisors LLC now owns 1,095 shares of the biotechnology company’s stock worth $465,000 after buying an additional 74 shares during the period. SEB Asset Management AB bought a new position in Axon Enterprise during the first quarter worth $6,729,000. Swiss National Bank lifted its holdings in Axon Enterprise by 7.6% in the first quarter. Swiss National Bank now owns 220,020 shares of the biotechnology company’s stock valued at $93,440,000 after buying an additional 15,600 shares during the period. Ascent Wealth Partners LLC boosted its position in Axon Enterprise by 3.8% during the first quarter. Ascent Wealth Partners LLC now owns 15,405 shares of the biotechnology company’s stock valued at $6,542,000 after acquiring an additional 568 shares during the last quarter. Finally, Gryphon Financial Partners LLC boosted its position in Axon Enterprise by 23.1% during the first quarter. Gryphon Financial Partners LLC now owns 1,128 shares of the biotechnology company’s stock valued at $479,000 after acquiring an additional 212 shares during the last quarter. 79.08% of the stock is currently owned by institutional investors.

Axon Enterprise Stock Performance

Shares of AXON opened at $527.76 on Friday. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.27 and a quick ratio of 1.93. The stock has a 50-day moving average of $497.09 and a 200-day moving average of $476.61. The company has a market cap of $42.54 billion, a PE ratio of 211.95, a P/E/G ratio of 10.72 and a beta of 1.38. Axon Enterprise, Inc has a one year low of $339.01 and a one year high of $885.91.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share for the quarter, topping analysts’ consensus estimates of $1.60 by $0.01. The business had revenue of $807.35 million for the quarter, compared to the consensus estimate of $778.90 million. Axon Enterprise had a return on equity of 3.78% and a net margin of 6.90%.The firm’s revenue for the quarter was up 33.7% on a year-over-year basis. During the same period in the prior year, the business earned $1.47 EPS. On average, equities research analysts predict that Axon Enterprise, Inc will post 1.63 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on AXON shares. Morgan Stanley set a $600.00 price objective on Axon Enterprise in a research report on Thursday, May 7th. Zacks Research lowered Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research report on Friday, July 10th. Piper Sandler raised their target price on Axon Enterprise from $674.00 to $724.00 and gave the stock an “overweight” rating in a research note on Monday, July 13th. Citizens Jmp reiterated a “market outperform” rating and issued a $700.00 target price on shares of Axon Enterprise in a report on Thursday, June 25th. Finally, TD Cowen reissued a “buy” rating on shares of Axon Enterprise in a research note on Wednesday, July 22nd. Fifteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, Axon Enterprise has an average rating of “Moderate Buy” and an average price target of $725.25.

Insider Activity

In other news, insider Elizabeth Reid Coughlin sold 1,554 shares of the company’s stock in a transaction that occurred on Thursday, June 4th. The stock was sold at an average price of $485.00, for a total transaction of $753,690.00. Following the transaction, the insider directly owned 34,024 shares of the company’s stock, valued at $16,501,640. This represents a 4.37% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Caitlin Elizabeth Kalinowski sold 564 shares of the stock in a transaction on Monday, June 1st. The stock was sold at an average price of $478.97, for a total value of $270,139.08. Following the completion of the transaction, the director owned 3,632 shares in the company, valued at approximately $1,739,619.04. This represents a 13.44% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 58,989 shares of company stock valued at $30,527,983. Corporate insiders own 4.20% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.